Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 11-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting TGF-β signaling in cancer

By Katz Lior H

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 743-760

Informa Healthcare

Access to resources Recommend Favorite

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

By Heinzle Christine Sutterlüüty Hedwig Grusch Michael Grasl-Kraupp Bettina Berger Walter Marian Brigitte

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 829-846

Informa Healthcare

Access to resources Recommend Favorite

Targeting signaling pathways in lung cancer therapy

By Cho William CS

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 107-111

Informa Healthcare

Access to resources Recommend Favorite

Advances in targeting the Hedgehog signaling pathway in cancer therapy

By Kiesslich Tobias Neureiter Daniel

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Targeting angiopoietin-2 signaling in cancer therapy

By Eroglu Zeynep Stein Cy A Pal Sumanta K

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 813-825

Informa Healthcare

Access to resources Recommend Favorite